AMSC vs. KNSA
AMSC (American Superconductor Corporation) and KNSA (Kiniksa Pharmaceuticals, Ltd.) are both stocks. AMSC operates in Specialty Industrial Machinery (Industrials), while KNSA operates in Biotechnology (Healthcare). Over the past 5 years, AMSC returned 24.53%/yr vs 29.69%/yr for KNSA. At a 0.25 correlation, their price movements are largely independent.
Performance
AMSC vs. KNSA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AMSC achieves a 50.80% return, which is significantly higher than KNSA's 33.60% return.
AMSC
- 1D
- 8.15%
- 1M
- -16.28%
- YTD
- 50.80%
- 6M
- 41.60%
- 1Y
- 42.76%
- 3Y*
- 86.23%
- 5Y*
- 24.53%
- 10Y*
- 17.89%
KNSA
- 1D
- 1.66%
- 1M
- 3.51%
- YTD
- 33.60%
- 6M
- 27.60%
- 1Y
- 93.78%
- 3Y*
- 52.43%
- 5Y*
- 29.69%
- 10Y*
- —
AMSC vs. KNSA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
AMSC American Superconductor Corporation | 50.80% | 16.85% | 121.10% | 202.72% | -66.18% | -53.54% | 198.34% | -29.60% | 63.01% |
KNSA Kiniksa Pharmaceuticals, Ltd. | 33.60% | 108.54% | 12.77% | 17.09% | 27.27% | -33.39% | 59.76% | -60.63% | 14.89% |
Correlation
The correlation between AMSC and KNSA is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since May 24, 2018 | 0.25 |
The correlation between AMSC and KNSA shifts across timeframes, from 0.12 (1 year) to 0.28 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
AMSC:
$2.03B
KNSA:
$4.54B
AMSC:
$3.05
KNSA:
$0.92
AMSC:
14.24
KNSA:
59.85
AMSC:
0.03
KNSA:
0.58
AMSC:
6.37
KNSA:
5.80
AMSC:
3.65
KNSA:
7.50
AMSC:
$299.15M
KNSA:
$754.05M
AMSC:
$91.38M
KNSA:
$294.06M
AMSC:
$19.29M
KNSA:
$101.06M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AMSC vs. KNSA — Risk / Return Rank
AMSC
KNSA
AMSC vs. KNSA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for American Superconductor Corporation (AMSC) and Kiniksa Pharmaceuticals, Ltd. (KNSA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AMSC | KNSA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.79 | ||
| Sortino ratioReturn per unit of downside risk | -2.10 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.41 | -0.24 |
| Calmar ratioReturn relative to maximum drawdown | 0.67 | 4.63 | -3.96 |
| Martin ratioReturn relative to average drawdown | 1.11 | 16.35 | -15.24 |
Loading charts...
Drawdowns
AMSC vs. KNSA - Drawdown Comparison
The maximum AMSC drawdown since its inception was -99.57%, which is greater than KNSA's maximum drawdown of -83.06%. Use the drawdown chart below to compare losses from any high point for AMSC and KNSA.
Loading charts...
Drawdown Indicators
| AMSC | KNSA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.57% | -83.06% | -16.51% |
Max Drawdown (1Y)Largest decline over 1 year | -61.08% | -21.12% | -39.96% |
Max Drawdown (3Y)Largest decline over 3 years | -63.86% | -34.14% | -29.72% |
Max Drawdown (5Y)Largest decline over 5 years | -82.94% | -53.17% | -29.77% |
Max Drawdown (10Y)Largest decline over 10 years | -89.06% | — | — |
Current DrawdownCurrent decline from peak | -93.73% | -7.35% | -86.38% |
Average DrawdownAverage peak-to-trough decline | -75.77% | -40.60% | -35.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 36.76% | 5.97% | +30.79% |
Volatility
AMSC vs. KNSA - Volatility Comparison
American Superconductor Corporation (AMSC) has a higher volatility of 22.71% compared to Kiniksa Pharmaceuticals, Ltd. (KNSA) at 10.40%. This indicates that AMSC's price experiences larger fluctuations and is considered to be riskier than KNSA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AMSC | KNSA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.71% | 10.40% | +12.31% |
Volatility (6M)Calculated over the trailing 6-month period | 55.16% | 34.02% | +21.14% |
Volatility (1Y)Calculated over the trailing 1-year period | 85.29% | 43.03% | +42.26% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 87.45% | 53.48% | +33.97% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 79.21% | 63.93% | +15.28% |
Dividends
AMSC vs. KNSA - Dividend Comparison
Neither AMSC nor KNSA has paid dividends to shareholders.
Financials
AMSC vs. KNSA - Financials Comparison
This section allows you to compare key financial metrics between American Superconductor Corporation and Kiniksa Pharmaceuticals, Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AMSC vs. KNSA - Profitability Comparison
AMSC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, American Superconductor Corporation reported a gross profit of 23.60M and revenue of 86.41M. Therefore, the gross margin over that period was 27.3%.
KNSA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported a gross profit of 0.00 and revenue of 214.27M. Therefore, the gross margin over that period was 0.0%.
AMSC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, American Superconductor Corporation reported an operating income of -522.00K and revenue of 86.41M, resulting in an operating margin of -0.6%.
KNSA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported an operating income of 29.27M and revenue of 214.27M, resulting in an operating margin of 13.7%.
AMSC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, American Superconductor Corporation reported a net income of 4.53M and revenue of 86.41M, resulting in a net margin of 5.2%.
KNSA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported a net income of 22.59M and revenue of 214.27M, resulting in a net margin of 10.5%.
Frequently Asked Questions
AMSC and KNSA have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AMSC has higher volatility (22.71%) compared to KNSA (10.40%). In terms of maximum drawdown, AMSC dropped -99.57% vs KNSA's -83.06%.
KNSA currently has the higher Sharpe Ratio (2.27 vs 0.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AMSC and KNSA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer